MMJ Schu
@Schu420
29 March, 12:24
Clemastine fumurate (Tavist)
was taken off the market in the US years ago, but still sold OTC elsewhere, has been shown in studies to protect against MYOCARDITIS through regulation of TLR4 ( toll like receptor 4).
https://www.ncbi.nlm.nih.g...
Also been studied as a remyelinating agent for those with MS.
https://pubmed.ncbi.nlm.ni...
was taken off the market in the US years ago, but still sold OTC elsewhere, has been shown in studies to protect against MYOCARDITIS through regulation of TLR4 ( toll like receptor 4).
https://www.ncbi.nlm.nih.g...
Also been studied as a remyelinating agent for those with MS.
https://pubmed.ncbi.nlm.ni...
Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Frontiers | Clemastine Fumarate Attenuates Myocardial Ischemia Reperfusion Injury Through Inhibition of Mast Cell Degranulation | Pharmacology
Mast cell (MC) activation is associated with myocardial ischemia reperfusion injury (MIRI). Suppression of MC degranulation might be a target of anti-MIRI. This study aimed to determine whether clemastine fumarate (CLE) could attenuate MIRI by inhibiting MC degranulation. A rat ischemia and reperfus..
https://www.frontiersin.org/articles/10.3389/fphar.2021.704852/full
02:22 PM - Mar 29, 2022
In response MMJ Schu to her Publication
Only people mentioned by Schu420 in this post can reply
